Literature DB >> 12614914

Rapid induction of insulin resistance in opioid mu-receptor knock-out mice.

Juei-Tang Cheng1, I-Min Liu, Chih Fen Hsu.   

Abstract

Role of opioid mu-receptor that has been showed to involve in the insulin-dependent diabetic rats in the induction of insulin resistance remains unclear. The present study is performed to clarify this point. The wild-type mice or opioid mu-receptor knockout mice were employed to induce insulin resistance by feeding with fructose-rich chow or by the repeated intraperitoneal injections of long-acting form of human insulin at 0.5 IU/kg three times daily. The basal plasma glucose concentration was not markedly changed in fructose-fed mice regardless the presence of opioid mu-receptor or not. However, the plasma glucose lowering activity of tolbutamide (10.0 mg/kg) disappeared rapidly in opioid mu-receptor knockout mice receiving fructose-rich chow as compared to that in wild type group. In opioid mu-receptor knockout mice, the elevation of plasma glucose concentration and the loss of plasma glucose lowering activity of tolbutamide were observed at 15 days after insulin injection. However, similar change was obtained at 21 days later of insulin injection in wild-type mice, showing that decrease of insulin action was more markedly in opioid mu-receptor knockout mice. Our results indicated that opioid mu-receptor is related to the delay of insulin resistance induced by fructose-fed method or insulin repeated injection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614914     DOI: 10.1016/s0304-3940(03)00002-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Authors:  Aamir R Zuberi; Leigh Townsend; Laurel Patterson; Huiyuan Zheng; Hans-Rudi Berthoud
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

2.  Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells.

Authors:  T-F Tzeng; I-M Liu; J-T Cheng
Journal:  Diabetologia       Date:  2005-06-15       Impact factor: 10.122

3.  Activation of nucleus accumbens μ-opioid receptors enhances the response to a glycaemic challenge.

Authors:  Laura L Koekkoek; Tess Kool; Leslie Eggels; Luna L van der Gun; Khalid Lamuadni; Margo Slomp; Charlene Diepenbroek; Mireillle J Serlie; Andries Kalsbeek; Susanne E la Fleur
Journal:  J Neuroendocrinol       Date:  2021-08-26       Impact factor: 3.870

4.  Myricetin Ameliorates Defective Post-Receptor Insulin Signaling via β-Endorphin Signaling in the Skeletal Muscles of Fructose-Fed Rats.

Authors:  Thing-Fong Tzeng; Shorong-Shii Liou; I-Min Liu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-04       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.